AVANOS MED INC's ticker is AVNS and the CUSIP is 05350V106. A total of 270 filers reported holding AVANOS MED INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $202,000 | -18.2% | 7,376 | 0.0% | 0.01% | 0.0% |
Q1 2022 | $247,000 | -31.8% | 7,376 | -29.3% | 0.01% | -30.8% |
Q4 2021 | $362,000 | -6.7% | 10,437 | -16.2% | 0.01% | -18.8% |
Q3 2021 | $388,000 | -14.3% | 12,449 | 0.0% | 0.02% | -11.1% |
Q2 2021 | $453,000 | -15.5% | 12,449 | +1.6% | 0.02% | -18.2% |
Q1 2021 | $536,000 | +0.6% | 12,254 | +5.5% | 0.02% | -8.3% |
Q4 2020 | $533,000 | +49.7% | 11,619 | +8.4% | 0.02% | +33.3% |
Q3 2020 | $356,000 | +13.0% | 10,722 | 0.0% | 0.02% | +5.9% |
Q2 2020 | $315,000 | +9.0% | 10,722 | 0.0% | 0.02% | -5.6% |
Q1 2020 | $289,000 | -40.3% | 10,722 | -25.3% | 0.02% | -21.7% |
Q4 2019 | $484,000 | -10.0% | 14,362 | 0.0% | 0.02% | -14.8% |
Q3 2019 | $538,000 | -14.1% | 14,362 | 0.0% | 0.03% | -15.6% |
Q2 2019 | $626,000 | -7.3% | 14,362 | -8.1% | 0.03% | -8.6% |
Q1 2019 | $675,000 | -3.7% | 15,635 | 0.0% | 0.04% | -12.5% |
Q4 2018 | $701,000 | -40.2% | 15,635 | -8.8% | 0.04% | -29.8% |
Q3 2018 | $1,173,000 | +1.6% | 17,135 | -15.0% | 0.06% | -3.4% |
Q2 2018 | $1,155,000 | – | 20,160 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Paradice Investment Management LLC | 2,482,743 | $113,908,000 | 6.40% |
RGM Capital, LLC | 1,984,455 | $91,047,000 | 3.97% |
Cove Street Capital, LLC | 204,438 | $9,380,000 | 1.66% |
Millrace Asset Group, Inc. | 41,200 | $1,890,000 | 1.32% |
Phocas Financial Corp. | 142,037 | $6,516,000 | 1.00% |
Champlain Investment Partners, LLC | 3,470,935 | $159,246,000 | 0.91% |
HEARTLAND ADVISORS INC | 231,533 | $10,623,000 | 0.76% |
CONFLUENCE INVESTMENT MANAGEMENT LLC | 481,042 | $22,070,000 | 0.33% |
Wakefield Asset Management LLLP | 14,653 | $672,000 | 0.28% |
S.A. Mason LLC | 6,527 | $299,000 | 0.25% |